ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 6 (1) 45-48    DOI: 10.1677/erc.0.0060045
Copyright © 1999 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (56)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, S.
Endocrine Related Cancer, Vol 6, Issue 1, 45-48
Copyright © 1999 by Society for Endocrinology


Articles

Activation of p53 by oncogenes

SW Lowe


p53 is activated by a variety of cellular stresses, including DNA damage, hypoxia, and mitogenic oncogenes, but the extent to which each signal engages p53 as a tumour suppressor remains unknown. In non-immortal cells, the adenovirus E1A oncogene activates p53 to promote apoptosis, whereas oncogenic ras activates p53 to promote cellular senescence. Inactivation of p53 prevents E1A-induced apoptosis or Ras-induced senescence, allowing proliferation to continue unabated. In each instance, the ability of the oncogene to activate p53 involves the same functions as are required for their transforming potential, implying that p53 activation acts as a fail-safe mechanism to counter hyperproliferative signals. Furthermore, p19(ARF) is strictly required for oncogene signalling to p53. The fact that ARF--itself a tumour suppressor--acts as an intermediary in this response argues that the tumour suppressor activity of p53 can arise from its ability to eliminate oncogene-expressing cells.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Garneau, L. Alvarez, M.-C. Paquin, C. Lussier, C. Rancourt, E. Tremblay, J.-F. Beaulieu, and N. Rivard
Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G758 - G772.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. B. Kopnin, L. S. Agapova, B. P. Kopnin, and P. M. Chumakov
Repression of Sestrin Family Genes Contributes to Oncogenic Ras-Induced Reactive Oxygen Species Up-regulation and Genetic Instability
Cancer Res., May 15, 2007; 67(10): 4671 - 4678.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H.-Y. Huang, P. B. Illei, Z. Zhao, M. Mazumdar, A. G. Huvos, J. H. Healey, L. H. Wexler, R. Gorlick, P. Meyers, and M. Ladanyi
Ewing Sarcomas With p53 Mutation or p16/p14ARF Homozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse
J. Clin. Oncol., January 20, 2005; 23(3): 548 - 558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Liao and M.-C. Hung
Regulation of the Activity of p38 Mitogen-Activated Protein Kinase by Akt in Cancer and Adenoviral Protein E1A-Mediated Sensitization to Apoptosis
Mol. Cell. Biol., October 1, 2003; 23(19): 6836 - 6848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. X. Zeng, Y. Jin, D. T. Kuninger, P. Rotwein, and H. Lu
The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization
J. Biol. Chem., February 21, 2003; 278(9): 7453 - 7458.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E.J. Wolvetang, T.J. Wilson, E. Sanij, J. Busciglio, T. Hatzistavrou, A. Seth, P.J. Hertzog, and I. Kola
ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway
Hum. Mol. Genet., February 1, 2003; 12(3): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. C. Hahn and R. A. Weinberg
Rules for Making Human Tumor Cells
N. Engl. J. Med., November 14, 2002; 347(20): 1593 - 1603.
[Full Text] [PDF]


Home page
J. Virol.Home page
S. L. Cole and M. J. Tevethia
Simian Virus 40 Large T Antigen and Two Independent T-Antigen Segments Sensitize Cells to Apoptosis following Genotoxic Damage
J. Virol., July 17, 2002; 76(16): 8420 - 8432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Wang, D. Michael, G. de Murcia, and M. Oren
p53 Activation by Nitric Oxide Involves Down-regulation of Mdm2
J. Biol. Chem., May 3, 2002; 277(18): 15697 - 15702.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. G. Breckenridge, M. Nguyen, S. Kuppig, M. Reth, and G. C. Shore
The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum
PNAS, April 2, 2002; 99(7): 4331 - 4336.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. H. Fisher, S. L. Wellen, D. Klimstra, J. M. Lenczowski, J. W. Tichelaar, M. J. Lizak, J. A. Whitsett, A. Koretsky, and H. E. Varmus
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
Genes & Dev., December 15, 2001; 15(24): 3249 - 3262.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
G. WAHL and O. VAFA
Genetic Instability, Oncogenes, and the p53 Pathway
Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 511 - 520.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Inoue, R. K. Geyer, D. Howard, Z. K. Yu, and C. G. Maki
MDM2 Can Promote the Ubiquitination, Nuclear Export, and Degradation of p53 in the Absence of Direct Binding
J. Biol. Chem., November 21, 2001; 276(48): 45255 - 45260.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. G. Breckenridge, M. Nguyen, S. Kuppig, M. Reth, and G. C. Shore
The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum
PNAS, April 2, 2002; 99(7): 4331 - 4336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.